The presence of the rs11568820 polymorphic variant in the promoter region of vitamin D and vitamin D deficiency could be considered to eventually guide treatment towards drugs with a different mechanism of action compared to anti-TNF agents. The gene discussed is TNF; the disease is vitamin D deficiency.